Table 1 Baseline demographics of study participants.

LDL, low-density lipoprotein; HDL, high-density lipoprotein; NSTI, integrase strand transfer inhibitors; NRTI, nucleoside reverse transcriptase inhibitor; NNRTI, non-nucleoside reverse transcriptase inhibitor; pi, protease inhibitor.

Seronegative
controls (n = 14)
PWH (n = 15)
Age (years)44 (21)46 (13)
Male, no. (%)7 (50%)8 (53%)
Race
  White non-Hispanic5 (35.5%)3 (20.0%)
  Black non-Hispanic4 (29.0%)6 (40.0%)
  Hispanic5 (35.5%)6 (40.0%)
Body mass index (kg/m2)25.6 (2.5)27.9 (10.7)
CD4 T cell count708 (380)
Smoking
  Never11 (78.6%)7 (46.7%)
  Past1 (7.1%)4 (26.7%)
  Current2 (14.3%)4 (26.7%)
ART, no. (%)
  Abacavir-based2 (13.0%)
  INSTI + 2 NRTI6 (40.0%)
  NNRTI + 2 NRTI2 (13.0%)
  PI + 2 NRTI6 (40.0%)
LDL (mg/dl)114 (30)99 (21)
HDL (mg/dl)52 (20)47 (22)
Total cholesterol (mg/dl)181 (53)169 (55)
Platelet count (×109/liter)221 (95)232 (124)